Jia Y - Search Results

1

Synthesis and biological characterization of ubenimex-fluorouracil conjugates for anti-cancer therapy.

Jiang Y, Li X, Hou J, Huang Y, Wang X, Jia Y, Wang Q, Xu W, Zhang J, Zhang Y. Jiang Y, et al. Among authors: jia y. Eur J Med Chem. 2018 Jan 1;143:334-347. doi: 10.1016/j.ejmech.2017.11.074. Epub 2017 Dec 1. Eur J Med Chem. 2018. PMID: 29202398

2

Discovery of N-hydroxy-4-(3-phenylpropanamido)benzamide derivative 5j, a novel histone deacetylase inhibitor, as a potential therapeutic agent for human breast cancer.

Feng J, Fang H, Wang X, Jia Y, Zhang L, Jiao J, Zhang J, Gu L, Xu W. Feng J, et al. Among authors: jia y. Cancer Biol Ther. 2011 Mar 1;11(5):477-89. doi: 10.4161/cbt.11.5.14529. Epub 2011 Mar 1. Cancer Biol Ther. 2011. PMID: 21263218 Free article.

3

Development of tetrahydroisoquinoline-based hydroxamic acid derivatives: potent histone deacetylase inhibitors with marked in vitro and in vivo antitumor activities.

Zhang Y, Feng J, Jia Y, Wang X, Zhang L, Liu C, Fang H, Xu W. Zhang Y, et al. Among authors: jia y. J Med Chem. 2011 Apr 28;54(8):2823-38. doi: 10.1021/jm101605z. Epub 2011 Apr 5. J Med Chem. 2011. PMID: 21476600

4

Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities.

Zhang Y, Fang H, Feng J, Jia Y, Wang X, Xu W. Zhang Y, et al. Among authors: jia y. J Med Chem. 2011 Aug 11;54(15):5532-9. doi: 10.1021/jm200577a. Epub 2011 Jul 11. J Med Chem. 2011. PMID: 21714538

5

Design, synthesis and primary activity assay of tripeptidomimetics as histone deacetylase inhibitors with linear linker and branched cap group.

Zhang Y, Feng J, Jia Y, Xu Y, Liu C, Fang H, Xu W. Zhang Y, et al. Among authors: jia y. Eur J Med Chem. 2011 Nov;46(11):5387-97. doi: 10.1016/j.ejmech.2011.08.045. Epub 2011 Sep 8. Eur J Med Chem. 2011. PMID: 21924799

6

Design, synthesis, and activity evaluation of a new 5-fluorouracil prodrug containing an Asn-Gly-Arg(NO2)COOCH3 tripeptide.

Luan Y, Jing F, Zhang J, Zou M, Wang X, Jia Y, Liu N, Mou J, Xu W. Luan Y, et al. Among authors: jia y. Protein Pept Lett. 2012 Oct;19(10):1122-31. doi: 10.2174/092986612802762615. Protein Pept Lett. 2012. PMID: 22512656

7

Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors.

Su L, Jia Y, Zhang L, Xu Y, Fang H, Xu W. Su L, et al. Among authors: jia y. Bioorg Med Chem. 2012 Jun 15;20(12):3807-15. doi: 10.1016/j.bmc.2012.04.035. Epub 2012 Apr 23. Bioorg Med Chem. 2012. PMID: 22607877

8

Discovery of novel vascular endothelial growth factor receptor 2 inhibitors: a virtual screening approach.

Zhang L, Wang X, Feng J, Jia Y, Xu F, Xu W. Zhang L, et al. Among authors: jia y. Chem Biol Drug Des. 2012 Dec;80(6):893-901. doi: 10.1111/cbdd.12036. Chem Biol Drug Des. 2012. PMID: 22913881

9

Discovery of a synthetic Aminopeptidase N inhibitor LB-4b as a potential anticancer agent.

Su L, Jia Y, Wang X, Zhang L, Fang H, Xu W. Su L, et al. Among authors: jia y. Bioorg Med Chem Lett. 2013 May 1;23(9):2512-7. doi: 10.1016/j.bmcl.2013.03.021. Epub 2013 Mar 13. Bioorg Med Chem Lett. 2013. PMID: 23528299

10

Design and synthesis of a tetrahydroisoquinoline-based hydroxamate derivative (ZYJ-34v), an oral active histone deacetylase inhibitor with potent antitumor activity.

Zhang Y, Liu C, Chou CJ, Wang X, Jia Y, Xu W. Zhang Y, et al. Among authors: jia y. Chem Biol Drug Des. 2013 Aug;82(2):125-30. doi: 10.1111/cbdd.12144. Epub 2013 Jul 1. Chem Biol Drug Des. 2013. PMID: 23581848 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,243 results

Search Page

Filters